Stem Cell Authority Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Jan '26 Jan 15, 2026	Aug '09 Aug 31, 2009	Aug '08 Aug 31, 2008	Aug '07 Aug 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Market Capitalization	183	14	15	13	5	10
Market Cap Growth	5213.61%	-5.88%	14.64%	150.00%	-46.84%	-
Enterprise Value	-	15	16	13	5	10
Last Close Price	0.01	0.08	0.09	0.15	0.06	0.08
PE Ratio	2.85	7.52	-	13.38	-	-
PS Ratio	54.91	4.14	490.19	11.35	-	-
PB Ratio	-1983.26	-149.54	-7.61	-15.60	-3.50	48.44
P/FCF Ratio	-	-	-	885.56	-	-
P/OCF Ratio	-	-	-	98.01	-	-
EV/Sales Ratio	-	4.51	531.31	11.35	-	-
EV/EBITDA Ratio	-	-	-	46.11	-	-
EV/EBIT Ratio	-	8.19	-	48.40	-	-
EV/FCF Ratio	-	-	-	885.51	-	-
Debt / Equity Ratio	-20.13	-20.13	-0.68	-1.60	-0.85	-
Debt / EBITDA Ratio	-	-	-	4.73	-	-
Debt / FCF Ratio	-	-	-	90.89	-	-
Asset Turnover	1.43	1.43	0.04	-	-	-
Inventory Turnover	59.76	59.76	2.84	-	-	-
Quick Ratio	0.97	0.97	0.00	0.05	0	-
Current Ratio	1.12	1.12	0.22	0.40	0	0.23
Return on Equity (ROE)	-	-	-	-	-	-42.38%
Return on Assets (ROA)	49.09%	49.09%	-120.32%	-	-196.43%	-14.03%
Return on Capital Employed (ROCE)	314.30%	314.30%	77.70%	-33.90%	43.10%	-25.40%
Earnings Yield	1.00%	13.30%	-9.47%	7.47%	-13.00%	-0.53%
FCF Yield	-	-	-	0.11%	-13.71%	-0.53%
Buyback Yield / Dilution	-309.67%	-	-105.06%	-109.32%	4.56%	29.71%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.